| Financial Year |
March 31 2023 |
| Monetary Funds |
2,029,150,885.69 |
| Held-for-trading Financial Assets |
401,998,737.18 |
| Notes Receivable |
93,845,625.27 |
| Accounts Receivable |
1,938,500,433.83 |
| Advances to Suppliers |
761,339,817.36 |
| Other Receivables |
68,625,925.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,352,050,607.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
66,117,629.60 |
| Total Current Assets |
9,178,910,954.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
60,441,093.20 |
| Long-term Equity Investment |
-- |
| Investment Properties |
6,243,827.58 |
| Fixed Assetes |
1,943,886,477.53 |
| Under-construction Projects |
307,158,094.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
283,504,898.69 |
| R&D expenses |
969,931.44 |
| Goodwill |
8,417,413.42 |
| Long-Term Deferred and Prepaid Expenses |
336,422.02 |
| Deferred Income Tax Assets |
354,247,983.24 |
| Other Non-Current Assets |
44,677,604.47 |
| Sub-Total of Non-Current Assets |
6,197,724,923.97 |
| Total Assets |
15,376,635,878.78 |
| Short-Term Loans |
315,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
490,546,465.91 |
| Accounts Payable |
1,352,129,549.11 |
| Accounts Received In Advance |
230,204.48 |
| Employee Compensation Payable |
73,695,189.98 |
| Taxes Payable |
30,342,534.14 |
| Interest Payable |
565.28 |
| Dividend Payable |
-- |
| Other payables |
189,241,677.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,201,831.97 |
| Other Current Liabilities |
369,005,695.76 |
| Sub-Total of Current Liabilities |
5,241,541,177.92 |
| Long-term Loans |
164,700,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
15,573,963.11 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
418,639,074.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,555,444,559.41 |
| Total Liabilities |
6,796,985,737.33 |
| Paid-In Capital(Or Share Stock) |
980,179,980.00 |
| Capital Surplus |
406,952,515.42 |
| Surplus Reserve |
625,178,089.82 |
| LESS:Treasury Stock |
136,466,388.09 |
| Undistributed Profits |
3,708,325,289.36 |
| Minority Stockholder's Interest |
627,096,033.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,952,554,107.78 |
| Owner's Equity（Stockholder's Equity） |
8,579,650,141.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,376,635,878.78 |
